Hyperbaric Chamber for Weight Loss: What the Science Says

hyperbaric chamber weight loss

hyperbaric oxygen therapy (HBOT) is not a weight loss treatment. No clinical trials have tested HBOT specifically for weight loss in humans, and no medical organization recommends it for that purpose. That said, a small body of research suggests HBOT may influence certain metabolic processes, including mitochondrial function, inflammation, and oxygen utilization. These effects are worth understanding honestly, even if they don’t add up to a weight loss solution. This is something we explore further in our treatment pricing.

While rodent studies show HBOT can reduce fat mass and improve lipid metabolism through AMPK activation and brown fat thermogenesis, no human clinical trials exist for weight loss. All evidence remains entirely preclinical.1

0
2025 Review (PMC12729986): HBOT in rodent obesity models reduced adipose tissue mass, improved lipid profiles, activated AMPK signaling, and stimulated brown adipose thermogenesis. Human clinical trials: zero. HBOT is not FDA-approved for weight loss or metabolic disorders.1
Review, 2025

Can HBOT Help You Lose Weight?

The short answer is: there is no evidence that HBOT directly causes weight loss. You will not step into a hyperbaric chamber, breathe pressurized oxygen, and burn fat as a result. Weight loss fundamentally requires a sustained caloric deficit through diet, exercise, or both. HBOT does not change this equation. For a deeper dive, check out our HBOT for diabetes. What HBOT does is deliver oxygen to tissues at concentrations far above what normal breathing provides. This has well-documented effects on wound healing, tissue repair, and certain medical conditions. Whether those oxygen-related changes extend to meaningful metabolic shifts in healthy people seeking weight loss is a separate question, and one the research has barely begun to address.

Proposed mechanisms for HBOT’s metabolic effects include improved mitochondrial function and enhanced fat oxidation. These findings from animal models have not been validated in human studies, and HBOT should not be presented as a weight loss solution.2

Metabolic Effects That May Be Relevant

While HBOT is not a metabolic therapy, some of its physiological effects touch on systems involved in energy production and fat metabolism. Here is what we know so far.

Mitochondrial Function

Mitochondria are the structures inside cells responsible for converting nutrients into usable energy. Research has shown that HBOT can stimulate mitochondrial biogenesis, the process of creating new mitochondria, particularly in tissues that have been damaged or oxygen-deprived. In theory, better mitochondrial function means more efficient energy production. However, this has primarily been studied in the context of injury recovery and aging, not weight management.

Oxygen Utilization and Exercise Capacity

Some studies on HBOT and athletic performance suggest that repeated sessions may improve how the body uses oxygen during physical exertion. If HBOT helps someone exercise more effectively or recover faster between workouts, that could indirectly support a weight loss program. But HBOT itself is not the exercise. It is a potential supporting factor, not a replacement for physical activity.

Inflammation and Metabolic Health

Chronic low-grade inflammation is associated with obesity, insulin resistance, and metabolic syndrome. HBOT has demonstrated anti-inflammatory effects in multiple clinical contexts. Reducing systemic inflammation could, in theory, improve metabolic function and make weight management easier. This connection is plausible but unproven as a pathway to weight loss.

Animal Studies on Fat Tissue

A handful of animal studies have explored how hyperbaric oxygen affects adipose (fat) tissue. Some rodent studies have reported changes in fat cell metabolism and reductions in body weight markers after repeated HBOT exposure. These are interesting findings, but animal models do not reliably predict human outcomes, especially for something as complex as body weight regulation.

What the Research Actually Shows

Transparency matters here, so let’s be specific about the state of the evidence. We cover this topic thoroughly in our 2024 study on HBOT and metabolic markers.

There are zero randomized controlled trials that have tested HBOT as a weight loss intervention in humans. None. The studies that get cited in discussions about HBOT and weight loss are typically investigating other conditions (diabetic wounds, traumatic brain injury, aging) and happen to measure metabolic markers as secondary outcomes.

A 2020 study published in Aging found that HBOT sessions in older adults were associated with changes in body composition, including some reduction in adipose tissue, but the study was designed to investigate aging and cognitive function, not weight loss. The sample was small and the participants were not overweight.

Several animal studies, primarily in mice and rats, have shown that HBOT exposure can influence lipid metabolism and reduce markers of obesity. A 2014 study in the International Journal of Obesity found that HBOT reduced body weight and fat mass in obese mice. These results are noteworthy for researchers exploring the biology of fat metabolism, but they are far from clinical evidence for human weight loss.

For a broader look at where the science stands on various HBOT applications, see our HBOT research overview.

When HBOT Might Indirectly Support Weight Goals

While HBOT will not cause weight loss on its own, there are scenarios where it could play a supporting role in someone’s broader health journey.

Faster Post-Surgical Recovery

People recovering from surgery, including bariatric surgery, joint replacements, or other procedures, often face weeks or months of limited mobility. HBOT’s ability to accelerate tissue healing may help patients return to physical activity sooner, which supports weight management during recovery. This is about recovery speed, not fat burning.

Chronic Pain Relief

Chronic pain is one of the biggest barriers to regular exercise. If someone with fibromyalgia, arthritis, or post-surgical pain finds that HBOT reduces their pain levels enough to be more active, the downstream effect could include weight loss. Again, the mechanism is indirect: HBOT reduces pain, reduced pain enables movement, movement supports weight goals.

Improved Energy and Motivation

Some HBOT users report feeling more energized and mentally clear after sessions. While these are subjective reports and not well-quantified in research, feeling better can make it easier to maintain the habits, consistent exercise, meal preparation, adequate sleep, that actually drive weight loss.

What HBOT Cannot Do for Weight Loss

It is important to state clearly what HBOT will not do, because misleading claims in this space erode trust and waste people’s money.

  • HBOT cannot replace a caloric deficit. No amount of pressurized oxygen changes the fundamental energy balance equation.
  • HBOT cannot target belly fat or spot-reduce. Spot reduction is a myth regardless of the technology involved.
  • HBOT is not a metabolism booster in any clinically meaningful sense. While it affects cellular oxygen use, this does not translate to burning more calories at rest.
  • HBOT should not be marketed as a weight loss treatment. Any provider doing so is getting ahead of the evidence.

If you are considering HBOT, pursue it for its evidence-supported applications and realistic benefits. If weight loss is your primary goal, your time and money are better spent on nutrition coaching, a structured exercise program, and medical evaluation for any underlying metabolic issues.

Who Should Not Try HBOT

HBOT is generally safe when administered by trained professionals, but it is not appropriate for everyone. Discuss your full medical history with your provider before starting treatment.

Absolute Contraindications

HBOT should not be used if you have:

  • Untreated pneumothorax (collapsed lung) – pressure changes can worsen this condition and become life-threatening
  • Certain chemotherapy drugs – bleomycin, cisplatin, doxorubicin, and disulfiram may interact dangerously with high-oxygen environments

Relative Contraindications

Your provider may need to take extra precautions or postpone treatment if you have:

  • Upper respiratory infection or sinus congestion – difficulty equalizing pressure can cause ear or sinus barotrauma
  • Seizure disorder – high-pressure oxygen can lower seizure threshold in susceptible individuals
  • Chronic obstructive pulmonary disease (COPD) – altered breathing drive may require modified protocols
  • High fever – increases the risk of oxygen toxicity
  • History of ear surgery or chronic ear problems – pressure equalization may be difficult or risky
  • Claustrophobia – may require sedation or use of a multiplace chamber instead
  • Pregnancy – insufficient safety data exists for routine use during pregnancy

Talk to Your Doctor First

Even if you do not have the conditions listed above, always consult your physician before starting HBOT, especially if you take insulin (blood sugar may drop during treatment), have a pacemaker or implanted device, or are currently taking any medications. For a full overview of HBOT side effects and risks, see our detailed guide.

What HBOT Can Actually Do for Metabolic Health

While HBOT is not a weight loss treatment, research suggests it may support several metabolic processes that are relevant to people working on their overall health.

Improved Insulin Sensitivity

A 2024 study published in the journal of PubMed-indexed research found that HBOT sessions improved fasting insulin levels and glucose uptake in participants with metabolic syndrome. The mechanism involves increased oxygen delivery to insulin-sensitive tissues, which may help cells respond more effectively to insulin. This does not cause weight loss directly, but insulin resistance is a common barrier to weight management that HBOT may help address as part of a broader treatment plan.

Reduced Systemic Inflammation

Chronic low-grade inflammation is closely linked to obesity and metabolic dysfunction. HBOT has been shown to reduce inflammatory markers including C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). Lower inflammation can improve energy levels, reduce fatigue, and support exercise tolerance, all of which indirectly support weight management efforts.

Mitochondrial Function

HBOT stimulates mitochondrial biogenesis, the creation of new mitochondria in cells. Mitochondria are responsible for converting food into energy. More efficient mitochondrial function means better energy metabolism at the cellular level. Again, this is not a direct weight loss mechanism, but it supports the metabolic infrastructure that influences how your body processes and uses calories.

Who Might Benefit from HBOT as Part of a Weight Management Program

HBOT is not a substitute for diet and exercise. It will not cause meaningful weight loss on its own. However, certain people may find it a useful complement to an existing program:

  • People with metabolic syndrome or insulin resistance: The insulin-sensitizing effects may help break through metabolic plateaus
  • Those with chronic inflammation: If inflammation is contributing to fatigue and limiting physical activity, reducing it may help you become more active
  • Post-bariatric surgery patients: Some clinics use HBOT to support tissue healing and recovery after surgical weight loss procedures
  • People recovering from injuries that limit exercise: HBOT may accelerate healing, allowing faster return to physical activity

If you are considering HBOT specifically for metabolic health benefits, look for a provider who can monitor relevant biomarkers (fasting insulin, CRP, metabolic panel) before and during treatment to track whether the therapy is making a measurable difference. For more on what HBOT treatment costs, see our pricing guide.

What the Research Does Not Support

To be direct: there are no published clinical trials showing that HBOT causes clinically meaningful weight loss. Claims that HBOT “burns fat,” “boosts metabolism enough to lose weight,” or is a “weight loss treatment” are not supported by current evidence. Any website, clinic, or product making these claims is misrepresenting the science. What the evidence does support is that HBOT can improve several metabolic markers that are relevant to overall health. Whether those improvements translate to weight loss depends entirely on the individual’s broader lifestyle, diet, exercise habits, and underlying medical conditions.

Frequently Asked Questions

How many calories does a hyperbaric chamber session burn?

There is no reliable data on calorie expenditure during HBOT sessions. You are lying still and breathing, so energy expenditure is minimal, likely similar to resting metabolic rate. Some sources estimate a slight increase in metabolic activity due to elevated oxygen levels, but the difference would be negligible compared to even a short walk. Do not choose HBOT expecting it to burn meaningful calories. Our Cleveland Clinic overview of hyperbaric oxygen therapy covers this in detail.

Can HBOT help with weight loss after bariatric surgery?

HBOT is not part of standard post-bariatric surgery protocols. However, some patients use it to support wound healing after surgery, and faster recovery could mean returning to physical activity sooner. If you are considering HBOT after bariatric surgery, discuss it with your surgical team. It should complement your recovery plan, not replace any part of it. You may also want to understand whether your insurance covers HBOT for post-surgical recovery.

Are there any risks to using HBOT for weight loss?

The risks of HBOT are the same regardless of why you are using it: ear and sinus barotrauma, temporary vision changes, and in rare cases, oxygen toxicity. The specific risk of using HBOT “for weight loss” is financial. You may spend significant money on a treatment that does not address your actual goal. HBOT sessions are not cheap, and pursuing them for an unproven indication means paying for hope rather than evidence.

References

  1. 2025 Review. “Review of Hyperbaric Oxygen Therapy as an Adjunctive Intervention for Weight Management.” PMC12729986. PMC12729986
  2. Rodent obesity model studies cited in the 2025 review. AMPK/GLUT4 signaling and brown adipose thermogenesis findings.

Medical Disclaimer

The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Seph Fontane Pennock

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website

Previous Article

Hyperbaric Chamber for Dementia: Can HBOT Improve Cognitive Function?

Next Article

Hyperbaric Chamber for Fertility: Emerging Research on HBOT & Reproduction

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

One Email a Week.
Better Health Decisions.

Weekly breakdowns of the latest HBOT, ozone therapy, and oxygen therapy research. Clinical insights, treatment protocols, and evidence-based guidance for patients and practitioners.
Trusted by patients, clinicians, and researchers worldwide